Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Sales | 0 | 10 | 1,010 | 10,530 | 11,050 |
| Gross Profit | 0 | 10 | 1,010 | 10,530 | 11,050 |
| Operating Expenses | 20,890 | 16,130 | 20,500 | 15,850 | 27,490 |
| Operating Income | -20,890 | -16,120 | -19,490 | -5,320 | -16,440 |
| Interest Expense | 3,960 | 260 | 210 | 220 | 330 |
| Other Income | 1,560 | -4,610 | 330 | 680 | -6,320 |
| Pre-tax Income | -23,290 | -20,990 | -19,370 | -4,860 | -23,090 |
| Net Income Continuous | -23,794 | -20,917 | -19,871 | -5,283 | -18,302 |
| Net Income Discontinuous | 0 | 0 | 0 | -190 | 0 |
| Net Income | $-23,290 | $-20,990 | $-19,370 | $-5,050 | $-23,090 |
| EPS Basic Total Ops | -54.80 | -153.57 | -158.37 | -67.19 | -213.56 |
| EPS Basic Continuous Ops | -54.77 | -149.09 | -158.21 | -46.46 | -164.88 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -1.67 | N/A |
| EPS Diluted Total Ops | -54.80 | -153.57 | -158.37 | -67.19 | -213.56 |
| EPS Diluted Continuous Ops | -54.77 | -149.09 | -158.21 | -46.46 | -164.88 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -1.67 | N/A |
| EBITDA(a) | $-16,690 | $-15,670 | $-18,690 | $-4,530 | $-14,690 |